Windlas Biotech Limited has scheduled a meeting with investors and analysts to discuss key topics related to the company's operations and performance. The interaction will take place virtually on 26th November at 4:00 PM onwards. Participants will have access to publicly available documents during the discussion, allowing for an in-depth review of the company's performance and strategic direction.